Atenolol and Peripheral sensorimotor neuropathy - a phase IV clinical study of FDA data

Summary:

Peripheral sensorimotor neuropathy is reported as a side effect among people who take Atenolol (atenolol), especially for people who are male, 60+ old, also take Quinine, and have Acute coronary syndrome.

The phase IV clinical study analyzes which people have Peripheral sensorimotor neuropathy when taking Atenolol. It is created by eHealthMe based on reports of 170,420 people who have side effects when taking Atenolol from the FDA, and is updated regularly.

What is Atenolol?

Atenolol has active ingredients of atenolol. It is often used in high blood pressure. eHealthMe is studying from 176,618 Atenolol users. Check the latest studies of Atenolol.

What is Peripheral sensorimotor neuropathy?

Peripheral sensorimotor neuropathy (damage to one or more of your peripheral nerves) is found to be associated with 186 drugs and 322 conditions by eHealthMe. Check the latest studies of Peripheral sensorimotor neuropathy.

On Jul, 22, 2026

170,420 people reported to have side effects when taking Atenolol.
Among them, 11 people (0.01%) have Peripheral sensorimotor neuropathy.

Could Atenolol cause Peripheral sensorimotor neuropathy?

Among these 11 people:

What is the gender of people who have Peripheral sensorimotor neuropathy when taking Atenolol? *

female: 9.09 %
male: 90.91 %

What is the age of people who have Peripheral sensorimotor neuropathy when taking Atenolol? *

What are other drugs people take besides Atenolol? *

What are other side effects people have besides Peripheral sensorimotor neuropathy? *

White Blood Cell Count Decreased: 3 people, 27.27%
Stress And Anxiety: 3 people, 27.27%
Ascites (accumulation of fluid in the abdominal cavity): 3 people, 27.27%
Back Pain: 3 people, 27.27%
Cardiac Failure Congestive: 3 people, 27.27%
Dizziness: 3 people, 27.27%
Hypoaesthesia (reduced sense of touch or sensation): 3 people, 27.27%
Intervertebral Disc Protrusion (spinal disc protrusion): 3 people, 27.27%
Neuropathy Peripheral (surface nerve damage): 3 people, 27.27%
Pleural Effusion (water on the lungs): 3 people, 27.27%

What are the existing conditions these people have? *

Acute Coronary Syndrome (acute chest pain and other symptoms that happen because the heart does not get blood): 4 people, 36.36%
Multiple Myeloma (cancer of the plasma cells): 2 people, 18.18%
Abdominal Discomfort: 2 people, 18.18%
Uveitis (inflammation of the uvea): 1 person, 9.09%
Heart Rate Irregular: 1 person, 9.09%
Device Related Infection: 1 person, 9.09%
Ankylosing Spondylitis (type of arthritis affecting the spine): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Atenolol and have Peripheral sensorimotor neuropathy?

- Check whether Peripheral sensorimotor neuropathy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Atenolol:

Atenolol (176,618 reports)

Browse all side effects of Atenolol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Peripheral sensorimotor neuropathy:

Peripheral sensorimotor neuropathy (186 drugs)

Browse all the conditions that are associated with Peripheral sensorimotor neuropathy:

Peripheral sensorimotor neuropathy (322 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on atenolol (the active ingredients of Atenolol) and Atenolol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.